http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0155235-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b533f04155c27ee4d1f7386843347425
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-81
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
filingDate 1985-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5401e94dad27a2da69a41f0f513d93cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b201a093e8c8b67aab895b7c9630bd
publicationDate 1985-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0155235-A2
titleOfInvention Treatment of vernal conjunctivitis
abstract Vernal conjunctivitis is treated by administration of an intravenously injectable form of a polyvalent, intact immunoglobulin (IgG).
priorityDate 1984-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2856939-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27503

Total number of triples: 19.